ストックスクリーナーアプリを入手
11.93
0.34%
0.04
アフターアワーズ：
11.93
Greenwich Lifesciences Inc (GLSI) 最新ニュース
Can trapped investors hope for a rebound in Greenwich LifeSciences Inc.Trade Entry Summary & High Conviction Buy Zone Picks - Newser
Greenwich LifeSciences stock initiated at Outperform by Noble Capital - Investing.com
Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences - GlobeNewswire
Signal strength of Greenwich LifeSciences Inc. stock in tech scannersMarket Rally & Smart Money Movement Tracker - Newser
Understanding Greenwich LifeSciences Inc.’s price movementWeekly Earnings Recap & Accurate Intraday Trading Signals - Newser
Greenwich LifeSciences Inc.’s volatility index tracking explainedMarket Sentiment Review & Entry Point Confirmation Signals - Newser
Predicting Greenwich LifeSciences Inc. trend using moving averages2025 Market Overview & Technical Pattern Based Signals - Newser
Real time scanner hits for Greenwich LifeSciences Inc. explainedJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Should you wait for a breakout in Greenwich LifeSciences Inc.Weekly Profit Report & Community Trade Idea Sharing - Newser
What makes Greenwich LifeSciences Inc. stock price move sharplyWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Can Greenwich LifeSciences Inc. hit a new high this monthPortfolio Update Report & Community Trade Idea Sharing Platform - Newser
BiomX’s mid-stage cystic fibrosis trial put on clinical hold; Santen makes a deal with RemeGen - Endpoints News
Applying big data sentiment scoring on Greenwich LifeSciences Inc.2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Will Greenwich LifeSciences Inc. Benefit From Sector Tailwinds2025 Technical Patterns & Accurate Technical Buy Alerts - theviewers.co.kr
Greenwich LifeSciences brings clinical trial management in-house - Investing.com
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team - The Manila Times
Vertical Integration Reshapes Biotech Innovation: Greenwich LifeSciences' Strategic Shift and Its Implications for Investors - AInvest
Greenwich LifeSciences to Build Internal Clinical Operations Team - AInvest
Cost-Cutting Strategy: Greenwich LifeSciences Brings Phase III Breast Cancer Trial In-House for Enhanced Control - Stock Titan
How to build a dashboard for Greenwich LifeSciences Inc. stockJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - Newser
How to read the order book for Greenwich LifeSciences Inc.Dividend Hike & Risk Controlled Daily Trade Plans - Newser
Forecasting Greenwich LifeSciences Inc. price range with options dataJuly 2025 Short Interest & AI Powered Market Entry Strategies - Newser
Greenwich LifeSciences Inc. stock prediction for this weekTrade Volume Summary & Long-Term Growth Portfolio Plans - Newser
What indicators show strength in Greenwich LifeSciences Inc.Share Buyback & Free Daily Entry Point Trade Alerts - Newser
Insiders Hold Significant Stake in Greenwich LifeSciences, Inc. - AInvest
Owning 53% in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) means that insiders are heavily invested in the company's future - Yahoo Finance
Is Greenwich LifeSciences Inc. forming a reversal pattern2025 Trading Volume Trends & Daily Chart Pattern Signal Reports - Newser
What machine learning models say about Greenwich LifeSciences Inc.2025 Valuation Update & Safe Capital Growth Tips - Newser
How Greenwich LifeSciences Inc. stock performs during market volatilityQuarterly Investment Review & Free Reliable Trade Execution Plans - Newser
Greenwich Lifesciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Why Greenwich LifeSciences Inc. stock attracts strong analyst attentionMarket Performance Recap & Advanced Technical Signal Analysis - Newser
Greenwich LifeSciences Inc.’s Beta Climbs After Market VolatilityQuarterly Market Summary & Low Risk Entry Point Guides - newsyoung.net
0.95%
0.90%
大文字化:
|
ボリューム (24 時間):